BRIEF-pSivida says primary endpoint met in utilization study of new Medidur inserter with smaller diameter needle

* Psivida corp says primary endpoint met in psivida's utilization study of new medidur inserter with smaller diameter needle
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.